Neurogene, Inc. (NGNE)
20.92
-0.34
(-1.60%)
USD |
NASDAQ |
Dec 12, 16:00
20.95
+0.03
(+0.14%)
After-Hours: 20:00
Neurogene Total Assets (Quarterly): 287.83M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CorMedix, Inc. | 750.86M |
| Verastem, Inc. | 176.85M |
| Anavex Life Sciences Corp. | 103.82M |
| Coherus Oncology, Inc. | 516.52M |
| Ocugen, Inc. | 57.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.29M |
| Shareholders Equity (Quarterly) | 265.54M |
| Debt to Equity Ratio | 0.0384 |
| Current Ratio | 18.37 |
| Net Debt Paydown Yield | 0.28% |